Abstract:Objective:To observe the effects of transurethral split of the prostate (TUSP) on the urodynamics, the sexual function and the quality of life of benign prostatic hyperplasia.Methods:Eighty patients with benign prostatic hyperplasia admitted to the Deqing People′s Hospital of Zhejiang Province from January 2017 to June 2019 were enrolled into the research objects prospectively. According to the random digits table method, they were divided into group A and group B, with 40 cases in each group. The group A was treated with TUSP, while the group B was treated with bipolar transurethral plasma kinetic prostatectomy (TUPKP). The operation time, intraoperative blood loss, bladder irrigation time, urinary catheter indwelling time, hospitalization time of the two groups were compared and surgical effects were evaluated. The changes of hemoglobin (Hb), serum sodium (Na), post-void residual volume (PVR), maximum urinary flow rate (Q max), international prostate symptom score (IPSS) and international index of erectile function score (IIEF-5), the quality of life index (QOL) of 2 groups before and after the operation were measured. Surgical complications were recorded. Results:The operation time, bladder irrigation time, urinary catheter indwelling time and hospital stay in group A were all shorter than that in group B: (15.63 ± 4.17) min vs. (58.79 ± 10.45) min, (6.26 ± 1.17) h vs. (45.51 ± 10.03) h, (3.07 ± 0.68) d vs. (5.67 ± 1.51) d, (3.63 ± 0.43) d vs. (6.08 ± 1.72) d, (18.32 ± 2.79) ml vs. (65.26 ± 20.64) ml, and there were statistical differences ( P<0.05); there were no statistical difference between 2 groups in surgical curative effect grade and Na 1 d after operation ( P>0.05); 1 day after operation, Hb in group A was higher than that in group B: (115.63 ± 9.78) g/L vs. (109.65 ± 8.36) g/L, and there was statistical difference ( P<0.05); PVR, Q max, IPSS, IIEF-5 and QOL 3 and 6 months after surgery were improved in 2 groups ( P<0.05), but the difference between 2 groups was not statistically significant ( P>0.05); the total complication rate in group A was lower than that in group B: 10.00% (4/40) vs. 27.50% (11/40), and there was statistical difference ( P<0.05). Conclusions:TUSP and TUPKP are equally effective in the treatment of benign prostatic hyperplasia, both of which can improve the symptoms of prostatic hyperplasia, improve the quality of life and improve sexual function. But TUSP has less intraoperative bleeding, shorter operation time, faster postoperative recovery, fewer complications, and higher safety.

Evaluation of benign prostatic hyperplasia with different therapies based on clinical physiology and patients' subjective experience indexes

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

A comparative study of two means of simultaneous treatment for benign prostate hyperplasia and bladder stone

Evaluation of Transurethral Resection, Vaporization and Contact Laser Prostatectomy for the Treatment of BPH

Comparison of Different Drugs on the Treatment of Benign Prostate Hyperplasia

An evaluation of transurethral plasma kinetic resection versus transurethral resection of the prostate for the treatment of symptomatic BPH

Experience in Diagnosis and Treatment for Small-Size Benign Prostatic Hyperplasia

A retrospection of 1345 cases of inpatients with Benign prostatic hyperplasia in the past 10 years

Symptomatic Comparison in Efficacy on Patients with Benign Prostatic Hyperplasia Treated with Two Therapeutic Approaches

Comparative Study of the Clinical Efficacy of Transurethral Enucleation of the Prostate and Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia

The Clinical Safety and Efficacy of PKRP and TURP in the Treatment of Patients with Benign Prostatic Hyperplasia Prostate(volume>60 Ml):A Compared Study

Comparison of Transurethral Photoselective Vaporization and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Hyperplasia

The efficacy of α1-adrenergic receptor blocker, 5α-reductase inhibitor or combination therapy in benign prostatic hyperplasia

Clinical analysis of BPH and BPH with chronic prostatitis

A clinic comparative study of transurethral bipolar vaporizations and TURP for the treatment of BPH

Comparation of the Predictive Value Between Ultrasonography and Urodynamics for the Efficacy of Transurethral Resection of Prostate in Benign Prostatic Hyperplasia Patients

Clinical analysis of transurethral resection of prostate and transurethral electrovaporization of prostate: a retrospective study of 5346 cases

To evaluate the efficacy and safety of different kinds of PDE5-Is with tamsulosin as a medical therapy for LUTS secondary to benign prostatic hyperplasia

[Cost and Effectiveness Analysis of Treatments for Benign Prostatic Hyperplasia].

Comparison of the Clinical Effectiveness of Transurethral Resection of the Prostate and Transurethral Vaporization-Resection of the Prostate